Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Non-Current Deferred Tax Liability (2016 - 2022)

Historic Non-Current Deferred Tax Liability for Amicus Therapeutics (FOLD) over the last 10 years, with Q4 2022 value amounting to $4.9 million.

  • Amicus Therapeutics' Non-Current Deferred Tax Liability rose 18.26% to $4.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was $4.9 million, marking a year-over-year increase of 18.26%. This contributed to the annual value of $4.9 million for FY2022, which is 18.26% up from last year.
  • Per Amicus Therapeutics' latest filing, its Non-Current Deferred Tax Liability stood at $4.9 million for Q4 2022, which was up 18.26% from $4.9 million recorded in Q3 2022.
  • Over the past 5 years, Amicus Therapeutics' Non-Current Deferred Tax Liability peaked at $6.5 million during Q1 2018, and registered a low of $4.9 million during Q4 2020.
  • Moreover, its 5-year median value for Non-Current Deferred Tax Liability was $5.1 million (2019), whereas its average is $5.5 million.
  • Per our database at Business Quant, Amicus Therapeutics' Non-Current Deferred Tax Liability plummeted by 9628.17% in 2018 and then skyrocketed by 69.44% in 2021.
  • Amicus Therapeutics' Non-Current Deferred Tax Liability (Quarter) stood at $6.5 million in 2018, then fell by 21.87% to $5.1 million in 2019, then decreased by 3.07% to $4.9 million in 2020, then rose by 0.69% to $4.9 million in 2021, then increased by 0.18% to $4.9 million in 2022.
  • Its Non-Current Deferred Tax Liability stands at $4.9 million for Q4 2022, versus $4.9 million for Q3 2022 and $4.9 million for Q2 2022.